The experimental framework of the study is divided into two phases.
In the first step, dog blood was drawn at T0 (n = 22) and T1 (n = 22) (dogs reported in
In the second step, unregulated cmiRNAs selected as candidate EC were validated by qPCR in a larger panel of dogs, including all dogs listed in